Listen to this lively discussion with BigData@Heart partners on how the insights obtained from heart failure registries could inform the path forward in terms of optimal treatment options for patients in Europe.

How can industry, academic researchers, and clinicians advance treatment options for heart failure (HF) in the European region, where cross-country differences in care delivery systems, access to innovative treatments, and clinical trial availability may mean variations in medical management of patients with otherwise similar characteristics?

To answer some of these questions, BigData@Heart’s webinar “European differences in heart failure registries” looked at how the insights obtained from two HF registries – one international and one European – inform the path forward in terms of optimal treatment options for HF patients in Europe.

Click here to watch the recording of the webinar.